Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M304952200 on June 24, 2003

J. Biol. Chem., Vol. 278, Issue 36, 34458-34466, September 5, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/36/34458    most recent
M304952200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gianní, M.
Right arrow Articles by Rochette-Egly, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gianní, M.
Right arrow Articles by Rochette-Egly, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The AF-1 and AF-2 Domains of RAR{gamma}2 and RXR{alpha} Cooperate for Triggering the Transactivation and the Degradation of RAR{gamma}2/RXR{alpha} Heterodimers*

Maurizio Gianní {ddagger}, Anne Tarrade §, Elisa Agnese Nigro ¶, Enrico Garattini ¶ and Cécile Rochette-Egly ||

From the Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) CNRS INSERM ULP, UMR 7104, BP 10142, 67404 Illkirch Cedex, France and Laboratorio di Biologia Molecolare, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy

In eukaryotic cells, liganded RAR{gamma}2/RXR{alpha} heterodimers activate the transcription of retinoic acid (RA) target genes and then are degraded through the ubiquitin-proteasome pathway. In this study, we dissected the role of the RAR{gamma}2 and RXR{alpha} partners as well as of their respective AF-1 and AF-2 domains in the processes of transactivation and degradation. RAR{gamma}2 is the "engine" initiating transcription and its own degradation subsequent to ligand binding. Integrity of its AF-2 domain and phosphorylation of its AF-1 domain are required for both the degradation and the transactivation of the receptor. Deletion of the whole AF-1 domain does not impair these processes but shifts the receptor toward other proteolytic pathways through RXR{alpha}. In contrast, RXR{alpha} plays only a modulatory role, cooperating with RAR{gamma}2 through its AF-2 domain and its phosphorylated AF-1 domain in both the transcription activity and the degradation of the RAR{gamma}2/RXR{alpha} heterodimers. Our results underline that the AF-1 and AF-2 domains of each heterodimer partner cooperate with one other and that this cooperation is relevant for both the transcription and degradation processes.


Received for publication, May 12, 2003 , and in revised form, June 23, 2003.

* This work was supported by funds from CNRS, INSERM, the Collège de France, the Hôpital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, and Bristol-Myers Squibb. This work was also supported by the "Associazione Italiana per la Ricerca contro il Cancro," the "Progetto Finalizzato Oncologia," Consiglio Nazionale delle Ricerche-Ministero dell'Università e della Ricerca Scientifica e Technologica, and the "Fondo d'Investimento per la Ricerca Biotecnologica." The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Supported by short term fellowships from Human Frontier Science Program, the Association pour la Recherche sur le Cancer, and the Fondazione Italiana per la Ricerca sul Cancro. Present adress: Laboratorio di Biologia Molecolare, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy.

§ Supported by the "Ligue Nationale contre le Cancer." Present address: Neurogénétique Moléculaire, E.O223, Génopole, 2 rue Gaston Crémieux, 91057 Evry Cedex, France.

|| To whom correspondence should be addressed: IGBMC, BP 10142, 67 404 Illkirch Cedex, CU de Strasbourg, France. Tel.: 33-3-88-65-34-59; Fax: 33-3-88-65-32-01; E-mail: cegly{at}igbmc.u-strasbg.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Gianni', A. Boldetti, V. Guarnaccia, A. Rambaldi, E. Parrella, I. Raska Jr., C. Rochette-Egly, G. Del Sal, A. Rustighi, M. Terao, et al.
Inhibition of the Peptidyl-Prolyl-Isomerase Pin1 Enhances the Responses of Acute Myeloid Leukemia Cells to Retinoic Acid via Stabilization of RAR{alpha} and PML-RAR{alpha}
Cancer Res., February 1, 2009; 69(3): 1016 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z. Vucetic, Z. Zhang, J. Zhao, F. Wang, K. J. Soprano, and D. R. Soprano
Acinus-S' Represses Retinoic Acid Receptor (RAR)-Regulated Gene Expression through Interaction with the B Domains of RARs
Mol. Cell. Biol., April 15, 2008; 28(8): 2549 - 2558.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Lattuada, P. Vigano, S. Mangioni, J. Sassone, S. Di Francesco, M. Vignali, and A. M. Di Blasio
Accumulation of Retinoid X Receptor-{alpha} in Uterine Leiomyomas Is Associated with a Delayed Ligand-Dependent Proteasome-Mediated Degradation and an Alteration of Its Transcriptional Activity
Mol. Endocrinol., March 1, 2007; 21(3): 602 - 612.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
M. A. Bogoyevitch and B. Kobe
Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases
Microbiol. Mol. Biol. Rev., December 1, 2006; 70(4): 1061 - 1095.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Narayanan, V. A. T. Sepulveda, M. Falzon, and N. L. Weigel
The Functional Consequences of Cross-talk between the Vitamin D Receptor and ERK Signaling Pathways Are Cell-specific
J. Biol. Chem., November 5, 2004; 279(45): 47298 - 47310.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D.-C. Arce, U. Soto, J. van Riggelen, E. Schwarz, H. z. Hausen, and F. Rosl
Ectopic Expression of Nonliganded Retinoic Acid Receptor {beta} Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
J. Biol. Chem., October 29, 2004; 279(44): 45408 - 45416.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement